Nov. 9, 2015 - AMA - CHICAGO –Two of the country’s preeminent health organizations, the American Heart Association (AHA) and the American Medical Association (AMA), today announced a new nationwide initiative aimed at addressing the growing burden of high blood pressure in the U.S.

Target: BP™ will support physicians and care teams in helping their patients with high blood pressure reach a blood pressure goal of lower than 140/90 mm Hg, based on current AHA guidelines.

Although Target: BP is the first major collaborative initiative between the AHA and AMA, both organizations have long recognized high blood pressure as a major health threat. Both already have a number of practice-based and community-based initiatives and online tools that are helping physicians improve blood pressure control among their patients and helping people understand and improve their high blood pressure. They’ll now synergize these efforts into a campaign that will further assist both providers and patients by enhancing high blood pressure awareness, understanding and management.
As part of Target: BP, hospitals, medical practices, practitioners and health services organizations will work with the AHA and AMA to raise awareness about high blood pressure and commit to high levels of control in their patient populations. Participants will work with the latest AHA guidelines on blood pressure, aiming for readings of lower than 140/90 mm Hg for each patient, with goals adjusted as new data drives any guideline revisions in the future. AHA and AMA will provide these groups with tools and resources, including the AHA/ACC/CDC Hypertension Treatment Algorithm, for achieving this goal and will recognize those who attain high levels of control.

Even prior to the official launch, more than 50 healthcare systems or clinics serving nearly 18 million people quickly committed to participate in Target: BP, and additional ones are poised to join.

One in three American adults — about 80 million people — has high blood pressure and that number is steadily climbing, despite the fact that high blood pressure can usually be easily treated. There is a substantial body of evidence showing that high blood pressure is a contributing factor to many major health conditions, including heart attack, heart failure, stroke, kidney failure and other disease consequences.

Data from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) supports recommendations for keeping blood pressure low. The final results of SPRINT are being presented this week at the AHA’s Scientific Sessions, but previously reported preliminary findings indicated that reducing systolic blood pressure to 120 mm Hg among study participants markedly reduced the combined rate of having a heart attack, acute coronary syndrome, heart failure or stroke and reduced mortality. The carefully done study was sponsored by the National Institutes of Health and examined more than 9,300 people.

More HCB News